Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals

Clinical trial NCT06875245 · RECRUITING

Trial details

NCT number: NCT06875245
Sponsor: Faculty Hospital Kralovske Vinohrady
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Wet Age-related Macular Degeneration

Start date: 2023-03-31
Primary completion: 2025-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.